Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Try a hands-on demonstration of our new Telescope™ Guide Extension Catheter and see TAVR in action on our interactive Anatomage table.
Thursday, September 26, 2019 9:00 a.m.–5:00 p.m.
Friday, September 27, 2019 9:00 a.m.–5:00 p.m.
Saturday, September 28, 2019 9:00 a.m.–2:00 p.m.
Hear about all the exciting things happening with Medtronic TAVR this year. Nina Goodheart, VP and General Manager of Structural Heart, tells all.
Thursday, September 26, 10:50 a.m.
Late-breaking Clinical Trial:
Onyx ONE
Onyx ONE: A Randomized Trial of a Durable-polymer Drug-eluting Stent vs. a Polymer-free Drug-coated Stent in Patients at High Risk of Bleeding Treated with 1-month DAPT
Presented by Stephan Windecker
Location: Main Arena I
Onyx ONE: A Randomized Trial of a Durable-polymer Drug-eluting Stent vs. a Polymer-free Drug-coated Stent in Patients at High Risk of Bleeding Treated with 1-month DAPT
Presented by Stephan Windecker
Main Arena I 0 TRANSPARENTEvolut™ TAVR Now FDA Approved For Low Risk ssAS Patients
Visit us to learn more about our expanded low risk symptomatic severe aortic stenosis U.S. indication — and what it means for you and your patients.
8:00 a.m.–5:00 p.m.
Collaborators in TAVR Workshop
Designed for heart teams at TAVR sites launched within the last 6-9 months. Topics include; TAVR Foundations: Building a Program; Maintaining and Accelerating. Contact your local TAVR Medtronic representative to register.
This is a Medtronic course in collaboration with CRF.
Location: Moscone South 155/157 Upper Mezzanine
Designed for heart teams at TAVR sites launched within the last 6-9 months. Topics include; TAVR Foundations: Building a Program; Maintaining and Accelerating. Contact your local TAVR Medtronic representative to register.
This is a Medtronic course in collaboration with CRF.
8:30 p.m.–10:00 p.m.
Women in Structural Heart Reception
A casual evening of discussion and networking to bring all women in structural heart together.
Location: Marianne’s Lounge; 360 Jessie Street
A casual evening of discussion and networking to bring all women in structural heart together.
Marianne’s Lounge; 360 Jessie Street 0 TRANSPARENT10:50 a.m.
Late-breaking Clinical Trial
Onyx ONE: A Randomized Trial of a Durable-Polymer Drug-Eluting Stent vs a Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding Treated With 1-Month DAPT
Presented by Stephan Windecker
Location: Main Arena I
Onyx ONE: A Randomized Trial of a Durable-Polymer Drug-Eluting Stent vs a Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding Treated With 1-Month DAPT
Presented by Stephan Windecker
Main Arena I 0 TRANSPARENT11:30 a.m.–12:30 p.m.
Onyx ONE: Data, Details, and Relevance to Your Clinical Practice Lunch Symposium
Location: Presentation Theater 4, Hall D
Onyx ONE: Data, Details, and Relevance to Your Clinical Practice Lunch Symposium
Presentation Theater 4, Hall D 0 TRANSPARENT8:00 p.m.
Onyx ONE Reception
Location: Everdene Rooftop
Virgin Hotels San Francisco
250 4th St.
San Francisco, CA
Onyx ONE Reception
Everdene Rooftop Virgin Hotels San Francisco 250 4th St. San Francisco, CA 0 TRANSPARENT8:00 p.m.
TAVR Medical Faculty Educator Event
Join us to learn more from Dr. Tang and Dr. Zahr about TAVR considerations for the low risk patient population.
Faculty: Dr. Gilbert Tang and Dr. Firas Zahr
Location: ALX by Alexander's Steakhouse
680 Folsom St. Suite 125, San Francisco CA 94107
Join us to learn more from Dr\. Tang about TAVR considerations for the low risk patient population.
Faculty: Dr. Gilbert Tang
ALX by Alexander's Steakhouse 680 Folsom St. Suite 125, San Francisco CA 94107 0 TRANSPARENT2:00–4:00 p.m.
Transapical I: Intrepid Device Description Results and Ongoing Studies
This is a key CRF scientific session.
Location: Moscone South 155/157 Upper Mezzanine
This is a key CRF scientific session.
Moscone South 155/157 Upper Mezzanine 0 TRANSPARENTEach workshop can accommodate up to 40 attendees. Due to limited seating, all interested attendees are strongly encouraged to show up at least 15 minutes prior to the start of each workshop as check-in will begin at this time.
8:00–9:30 a.m.
TAVR Clinic Foundations for Valve Program Coordinator New to TAVR
An interactive journey through the TAVR Care Continuum with hands-on simulation and imaging.
An interactive journey through the TAVR Care Continuum with hands-on simulation and imaging.
0 TRANSPARENT10:00–11:30 a.m.
TAVR Foundations for the New to TAVR Implanter
Overview of the Evolut™ TAVR procedure and key imaging measurements with hands-on simulation and imaging.
Overview of the Evolut™ TAVR procedure and key imaging measurements with hands-on simulation and imaging.
0 TRANSPARENT12:00–1:30 p.m.
SPYRAL HTN ON MED, OFF MED, What Next?
Update on the SPYRAL HTN clinical trial program, latest advances in the procedure, RDN hands-on with simulation.
Update on the SPYRAL HTN clinical trial program, latest advances in the procedure, RDN hands-on with simulation.
0 TRANSPARENT2:00–3:30 p.m.
CTO PCI: Case Reviews Focusing on Procedural Planning, Device Selection and Technical Approaches
A comprehensive approach to CTO PCI that includes the latest tools, tips, and imaging techniques.
A comprehensive approach to CTO PCI that includes the latest tools, tips, and imaging techniques.
0 TRANSPARENT4:00-5:30 p.m.
Bifurcation PCI: A Step by Step Training Approach (Visible Heart) (For Non-US Physicians)
Leveraging insights gained from experiences at the Visible Heart™ Lab and hands-on simulation of bifurcation lesions.
Leveraging insights gained from experiences at the Visible Heart™ Lab and hands-on simulation of bifurcation lesions.
0 TRANSPARENT8:00–9:30 a.m.
Who is my Potential RDN Candidate? Interactive Discussion on RDN Candidate Selection
Discuss the different aspects of selection for potential RDN candidates.
Discuss the different aspects of selection for potential RDN candidates.
0 TRANSPARENT10:00–11:30 a.m.
Bifurcation PCI: A Step by Step Training Approach (Visible Heart) (For Non-US Physicians)
Leveraging insights gained from experiences at the Visible Heart™ Lab and hands-on simulation of bifurcation lesions.
Leveraging insights gained from experiences at the Visible Heart™ Lab and hands-on simulation of bifurcation lesions.
0 TRANSPARENT12:00–1:30 p.m.
Onyx ONE and the High Bleeding Risk Patient: Real World Case Reviews and Discussion†
With the release of the primary endpoint for Onyx ONE, the impact for treatment will be collaboratively discussed.
With the release of the primary endpoint for Onyx ONE, the impact for treatment will be collaboratively discussed.
0 TRANSPARENT2:00–3:30 p.m.
TAVR in Bicuspid Aortic Valves Training Workshop
Expert faculty will provide didactic instruction, case demonstrations, and an interactive workshop using real-world case examples and 3D imaging software.
Expert faculty will provide didactic instruction, case demonstrations, and an interactive workshop using real-world case examples and 3D imaging software.
0 TRANSPARENT4:00–5:30 p.m.
Contemporary Considerations for TAVR Hemodynamics Training Workshop
An expert panel will lead interactive, case-based discussions around the importance of hemodynamics, durability, and patient-prosthesis mismatch (PPM) in TAVR patients.
An expert panel will lead interactive, case-based discussions around the importance of hemodynamics, durability, and patient-prosthesis mismatch (PPM) in TAVR patients.
0 TRANSPARENT8:00–9:30 a.m.
Onyx ONE and the High Bleeding Risk Patient: Real World Case Reviews and Discussion†
An interactive journey through real-world cases of PCI in the patient at high risk of bleeding: success and failure.
An interactive journey through real-world cases of PCI in the patient at high risk of bleeding: success and failure.
0 TRANSPARENT10:00–11:30 a.m.
Bifurcation PCI: A Step by Step Training Approach (Visible Heart) For Non-US Physicians
Leveraging insights gained from experiences at the Visible Heart™ Lab and hands-on simulation of bifurcation lesions.
Leveraging insights gained from experiences at the Visible Heart™ Lab and hands-on simulation of bifurcation lesions.
0 TRANSPARENT12:00–1:30 p.m.
Low Risk TAVR: Case Selection and Lifetime Treatment Pathway Considerations
An expert panel will lead an interactive, case-based discussion around the appropriate treatment options for the low risk patient.
An expert panel will lead an interactive, case-based discussion around the appropriate treatment options for the low risk patient.
0 TRANSPARENT2:00–3:30 p.m.
How Things Work - The Science of RDN
Insights on the mechanism of RF ablations for renal denervation. Understanding preclinical tissue samples.
Insights on the mechanism of RF ablations for renal denervation. Understanding preclinical tissue samples.
0 TRANSPARENT4:00–5:30 p.m.
Tips, Tools, and Techniques for Successful Post-TAVR PCI
Interactive, case-based discussion of post-TAVR PCI tips and techniques with opportunity to practice techniques using hands-on simulation.
Interactive, case-based discussion of post-TAVR PCI tips and techniques with opportunity to practice techniques using hands-on simulation.
0 TRANSPARENTVisit our booth throughout the conference for these hands-on experiences and more.
A clinical trial option for patients with severe mitral regurgitation.
SEE MORETWITTER, TWEET, RETWEET, and the Twitter logo are trademarks of Twitter, Inc. or its affiliates.
Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.
Medtronic is continuing to advance DAPT evidence with the Onyx ONE Month Clear Study in the US and Japan. This evidence is anticipated to be available in 2020 and will be combined with the Onyx ONE Global Study data per the study design.
Deliverability bench testing: Telescope™ GEC 6 F vs. GuideLiner™* V3 5.5 F/6 F vs. Guidezilla™* II 6 F. Bench test data may not be indicative of clinical performance.